Correlations of EGFR mutations and increases in EGFR and HER2 copy number to gefitinib response in a retrospective analysis of lung cancer patients.
about
Not all epidermal growth factor receptor mutations in lung cancer are created equal: Perspectives for individualized treatment strategyRole of HER2 in NSCLCLaser capture microdissection and protein microarray analysis of human non-small cell lung cancer: differential epidermal growth factor receptor (EGPR) phosphorylation events associated with mutated EGFR compared with wild typeMolecular pathways and therapeutic targets in lung cancerAllelotypes of lung adenocarcinomas featuring ALK fusion demonstrate fewer onco- and suppressor gene changes.Mutations in epidermal growth factor receptor gene in esophageal squamous cell carcinoma patients in kashmir- a high incidence area of India.Mutated KRAS Is an Independent Negative Prognostic Factor for Survival in NSCLC Stage III Disease Treated with High-Dose RadiotherapyEpidermal growth factor receptor abnormalities in the pathogenesis and progression of lung adenocarcinomas.Data resources for the identification and interpretation of actionable mutations by clinicians.HER2 amplification: a potential mechanism of acquired resistance to EGFR inhibition in EGFR-mutant lung cancers that lack the second-site EGFRT790M mutationEpidermal growth factor receptor exon 20 p.S768I mutation in non-small cell lung carcinoma: A case report combined with a review of the literature and investigation of clinical significanceEvaluation of 7q31 region improves the accuracy of EGFR FISH assay in non small cell lung cancer.Novel mRNA isoforms and mutations of uridine monophosphate synthetase and 5-fluorouracil resistance in colorectal cancer.[The predictive value of EGFR status in non-small cell lung cancer patients treated with EGFR-TKIs].Simpson's paradox - aggregating and partitioning populations in health disparities of lung cancer patients.
P2860
Q26744284-456D460C-53CB-4489-B666-100043485F6AQ26781683-D1A9E2F9-B51A-4DD8-936F-77FFD5F374D5Q33358603-26C2B076-8AA0-45A0-901C-028DC52E2001Q33688872-FA51D353-29DE-44C7-BC95-E46A9B82254CQ34536679-5BC87735-7D54-4404-B3AF-16543E08F66DQ34747189-052FFF20-E15C-4F22-AE68-F3BEF6DD5FE6Q35623628-78D7DCD3-F727-4B5A-B717-5F81CC6687F2Q36014004-F67D1FB6-66B9-40FD-B91F-E009EAE04AE1Q36317783-EE437C08-46B8-4838-9440-3BD8AE4E2862Q36322762-573E0A38-5D7D-41CB-BDD2-41BDDA427BB4Q36503084-D30E5691-ED54-49F8-94F5-24E63B883696Q37432535-34847603-33EB-4E80-9B76-978DA6CB75BCQ39411361-43C75E94-994C-4DF2-BB5E-5E5301EBBCABQ42949613-0F61A771-D8D4-4130-86C2-B47B238C42E6Q46505499-6D8138B2-2907-4A31-A0B1-7F0A58C61D99
P2860
Correlations of EGFR mutations and increases in EGFR and HER2 copy number to gefitinib response in a retrospective analysis of lung cancer patients.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Correlations of EGFR mutations ...... lysis of lung cancer patients.
@ast
Correlations of EGFR mutations ...... lysis of lung cancer patients.
@en
Correlations of EGFR mutations ...... lysis of lung cancer patients.
@nl
type
label
Correlations of EGFR mutations ...... lysis of lung cancer patients.
@ast
Correlations of EGFR mutations ...... lysis of lung cancer patients.
@en
Correlations of EGFR mutations ...... lysis of lung cancer patients.
@nl
prefLabel
Correlations of EGFR mutations ...... lysis of lung cancer patients.
@ast
Correlations of EGFR mutations ...... lysis of lung cancer patients.
@en
Correlations of EGFR mutations ...... lysis of lung cancer patients.
@nl
P2093
P2860
P356
P1433
P1476
Correlations of EGFR mutations ...... lysis of lung cancer patients.
@en
P2093
Barbara Melosky
Chris Salski
Doug Horsman
Janessa J Laskin
Jeurgen Vielkind
John English
Lorena Barclay
P2860
P2888
P356
10.1186/1471-2407-7-128
P407
P577
2007-07-13T00:00:00Z
P5875
P6179
1029900847